Anika Therapeutics Inc (NASDAQ:ANIK)

39.46
Delayed Data
As of Mar 04
 0.00 / 0.00%
Today’s Change
34.16
Today|||52-Week Range
51.40
-3.14%
Year-to-Date

Today’s Trading

Previous close39.46
Today’s open39.05
Day’s range38.86 - 39.91
Volume155,395
Average volume (3 months)160,466
Market cap$586.1M
Dividend yield--
Data as of 3:59pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+80.58%
Earnings growth (this year)-42.03%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+40.64%
P/E ratio16.4
Price/Sales5.66
Price/Book3.29

Competitors

 Today’s
change
Today’s
% change
XENTIntersect ENT Inc-0.82-3.17%
BLCMBellicum Pharmaceuti...+0.92+3.93%
INGNInogen Inc+0.47+1.41%
ATRIAtrion Corp-2.57-0.79%
Data as of 4:00pm ET, 03/04/2015

Financials

Next reporting dateApril 28, 2015
EPS forecast (this quarter)$0.22
Annual revenue (last year)$105.6M
Annual profit (last year)$38.3M
Net profit margin36.29%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Francesco J. Luppino
Corporate headquarters
Bedford, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account